Sanofi (SNY) Deferred Taxes (2018 - 2025)

Sanofi has disclosed Deferred Taxes across 8 years of filings, most recently posting -$2.8 billion for Q4 2025.

• In Q4 2025, Deferred Taxes fell 231.28% year-over-year to -$2.8 billion; the TTM figure through Dec 2025 stood at -$5.6 billion (down 76.46% YoY), while the FY2025 annual figure was -$2.8 billion, down 227.07% from the prior year.
• Deferred Taxes came in at -$2.8 billion for Q4 2025 at Sanofi, down from -$857.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of -$407.3 million in Q4 2021 to a low of -$2.8 billion in Q4 2025.
• Average Deferred Taxes over 5 years is -$1.2 billion, with a median of -$857.0 million recorded in 2024.
• Year-over-year, Deferred Taxes surged 35.4% in 2024 and plunged 231.28% in 2025.
• Over 5 years, Deferred Taxes stood at -$407.3 million in 2021, then tumbled by 44.8% to -$589.7 million in 2022, then plunged by 124.97% to -$1.3 billion in 2023, then soared by 35.4% to -$857.0 million in 2024, then sank by 231.28% to -$2.8 billion in 2025.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$2.8 billion in Q4 2025, -$857.0 million in Q4 2024, and -$1.3 billion in Q4 2023.